04/07/2025
3:18 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:41 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:46 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:49 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/03/2025
3:33 PM | Bancel Stephane (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/21/2025
6:11 AM | Moderna (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/21/2025
6:14 AM | Moderna (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/14/2025
3:15 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2025
5:30 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/12/2025
8:07 AM | BAILLIE GIFFORD & CO (Filed by)
Moderna (Subject)
| Form SCHEDULE 13G/A | |
01/13/2025
6:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for MRNA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Moderna and its competitors with MarketBeat's FREE daily newsletter. |
01/06/2025
3:38 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/09/2024
2:18 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/06/2024
3:51 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/06/2024
3:55 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/03/2024
2:23 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/02/2024
3:26 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:15 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/02/2024
3:19 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/29/2024
2:49 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
2:54 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/29/2024
2:35 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
11/07/2024
5:33 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/08/2024
3:19 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/04/2024
7:49 AM | Hussain Abbas (Reporting)
Moderna (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
10/04/2024
7:52 AM | Hussain Abbas (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/02/2024
6:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/12/2024
5:03 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/10/2024
3:15 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
2:29 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/04/2024
4:42 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/04/2024
3:26 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/03/2024
2:42 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/30/2024
3:34 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/30/2024
3:37 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:45 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
3:30 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/13/2024
3:33 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/07/2024
3:02 PM | Moderna (Issuer)
Rubenstein David M. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
08/02/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/01/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Controversial opinion: Volume isn't enough. (Ad) Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if supply is just as high.
That’s why Tim Bohen created a new indicator designed to pinpoint stocks with high demand and low supply — the ideal setup for explosive moves. Tim Bohen’s new indicator reveals the perfect trade setup: high demand, low supply. |
07/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/23/2024
6:05 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/17/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/15/2024
10:44 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/12/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/10/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/09/2024
3:34 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/08/2024
2:28 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/28/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/26/2024
3:19 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/21/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/18/2024
3:28 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/17/2024
11:45 AM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/14/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
3:20 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
6:01 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:41 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/11/2024
4:26 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/10/2024
2:16 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:22 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/04/2024
4:27 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/04/2024
4:20 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/03/2024
2:36 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024
2:11 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/31/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/30/2024
3:36 PM | Mock James M (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
3:34 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
3:12 PM | Klinger Shannon Thyme (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/29/2024
2:12 PM | Mock James M (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:14 PM | Garay Arpa (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:20 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024
2:22 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Mock James M (Reporting)
Mock James M (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/28/2024
2:21 PM | Klinger Shannon Thyme (Reporting)
Moderna (Subject)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/22/2024
3:27 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/15/2024
3:23 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/15/2024
12:41 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/13/2024
3:03 PM | Hoge Stephen (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
3:43 PM | Hoge Stephen (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/08/2024
3:24 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/07/2024
3:51 PM | LANGER ROBERT (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:54 PM | Horning Sandra (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:57 PM | Moderna (Issuer)
Tallett Elizabeth E (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
The Last Time This Happened, Americans Lost Billions (Ad) Wall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warning signs are everywhere. Economist Addison Wiggin reveals what’s coming. Vegas summit just revealed a $36T event. See the video |
05/07/2024
3:59 PM | Moderna (Issuer)
SAGAN PAUL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
4:02 PM | Moderna (Issuer)
Nader Francois (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/07/2024
3:42 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/02/2024
5:31 AM | Moderna (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/26/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/24/2024
3:21 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
04/19/2024
6:00 PM | AFEYAN NOUBAR (Reporting)
Moderna (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/17/2024
3:17 PM | AFEYAN NOUBAR (Reporting)
Moderna (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
